We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boehringer Ingelheim, Circuit Therapeutics Join Forces to Discover Obesity Drugs
Boehringer Ingelheim, Circuit Therapeutics Join Forces to Discover Obesity Drugs
Boehringer Ingelheim is aiming to broaden its research into diabetes and other cardiometabolic diseases via a partnership with Circuit Therapeutics to develop novel drugs to treat obesity.